Literature DB >> 23553512

Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.

Elisabeth Lilian Pia Sattler1, Jung Sun Lee, Matthew Perri.   

Abstract

Medication nonadherence is a significant public health problem that affects the health and well-being of older Americans while burdening the US healthcare system. Pharmacy claims data have gained importance in deriving objective medication (re)fill adherence measures; however, little is known about application of such measures in older Americans. The objective of this study was to assess the types and characteristics of pharmacy claims-derived medication (re)fill adherence measures used in older Americans. A comprehensive literature search strategy was employed to identify all articles using pharmacy claims data to measure (re)fill adherence to prescription medications in older Americans aged 65+ years. Included were articles reporting original research studies conducted and published in the USA in English between 1 January 2000 and 1 November 2012. The basic search used multiple key terms indicating adherence, combined with the term "medication" and the term "pharmacy claims or administrative claims." Due to the variety of measure names used in the literature, a more specific search was added to repeat the basic search for 29 previously used medication (re)fill adherence measure names. Articles identified through the database search were manually reviewed to select only articles meeting the inclusion criteria. The search resulted in a total of 36 articles. Information on medication (re)fill measurements were extracted and summarized. The 36 articles used 20 differently named measures under the three main concepts: medication adherence, persistence, and discontinuation. Measures of medication adherence cumulatively assessed the proportion of time at which medications were (not) filled over a predefined observation period (e.g., medication possession ratio). Measures of medication persistence assessed the continuity of medication filling over a specified time period, while medication discontinuation measures focused on termination of medication (re)fills. Overall, almost two thirds of all identified articles used a single medication (re)fill adherence measure. Among them, 77 % used a medication possession measure. The term "medication possession ratio" (MPR) was used most frequently (65 %), followed by the "proportion of days covered" (PDC; 30 %). No single measure can be generally recommended for the use in older Americans. The challenges in using pharmacy claims-based medication (re)fill adherence measures in older Americans include a lack of consensus terminology and algorithms among measures of the same concepts, insufficient transparency of individual measure operationalization, and inadequate consideration of unique characteristics of the older population, such as temporary nursing home care. Although medication (re)fill adherence measures may be well suited for measuring medication adherence in older Americans, little guidance is available on how to use them in this population. Further efforts need to be given to the development and standardization of pharmacy claims-based medication (re)fill measures that are specifically tailored toward use in older Americans.

Entities:  

Mesh:

Year:  2013        PMID: 23553512     DOI: 10.1007/s40266-013-0074-z

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  55 in total

1.  A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use.

Authors:  R Balkrishnan; D B Christensen
Journal:  J Asthma       Date:  2001-02       Impact factor: 2.515

Review 2.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

3.  Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.

Authors:  Lisa Mucha; Sara Shaohung; Brian Cuffel; Thomas McRae; Tami L Mark; Megan Del Valle
Journal:  J Manag Care Pharm       Date:  2008-06

4.  The economics of improving medication adherence in osteoporosis: validation and application of a simulation model.

Authors:  Amanda R Patrick; John T Schousboe; Elena Losina; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2011-07-06       Impact factor: 5.958

5.  Compliance with osteoporosis medications.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Joel S Finkelstein; Marilyn Arnold; Jennifer M Polinski; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders.

Authors:  Matthew S Keene; Michael T Eaddy; Winnie W Nelson; Matthew W Sarnes
Journal:  Am J Manag Care       Date:  2005-10       Impact factor: 2.229

7.  An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.

Authors:  Sudeep Karve; Mario A Cleves; Mark Helm; Teresa J Hudson; Donna S West; Bradley C Martin
Journal:  Med Care       Date:  2008-11       Impact factor: 2.983

8.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension.

Authors:  Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner
Journal:  Am J Manag Care       Date:  2009-01       Impact factor: 2.229

9.  RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.

Authors:  J R Curtis; A O Westfall; H Cheng; K G Saag; E Delzell
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

10.  Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.

Authors:  Michael Dickson; Craig A Plauschinat
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

View more
  50 in total

1.  Medication adherence: A practical measurement selection guide using case studies.

Authors:  Leah L Zullig; Phil Mendys; Hayden B Bosworth
Journal:  Patient Educ Couns       Date:  2017-02-10

2.  Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Authors:  Ariel R Green; Liza M Reifler; Cynthia M Boyd; Linda A Weffald; Elizabeth A Bayliss
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

Review 3.  Improving medication adherence in migraine treatment.

Authors:  Elizabeth K Seng; Jeanetta A Rains; Robert A Nicholson; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2015-06

4.  Comparison of Pharmacy Database Methods for Determining Prevalent Chronic Medication Use.

Authors:  Timothy S Anderson; Bocheng Jing; Charlie M Wray; Sarah Ngo; Edison Xu; Kathy Fung; Michael A Steinman
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

5.  A systematic review of methods for determining cross-sectional active medications using pharmacy databases.

Authors:  Timothy S Anderson; Edison Xu; Evans Whitaker; Michael A Steinman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-13       Impact factor: 2.890

6.  Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases.

Authors:  Margret V Bjarnadottir; David Czerwinski; Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

7.  The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.

Authors:  David J Taber; James N Fleming; Cory E Fominaya; Mulugeta Gebregziabher; Kelly J Hunt; Titte R Srinivas; Prabhakar K Baliga; John W McGillicuddy; Leonard E Egede
Journal:  Am J Nephrol       Date:  2016-12-02       Impact factor: 3.754

8.  In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

Authors:  Katrin Krueger; Nina Griese-Mammen; Ingrid Schubert; Marita Kieble; Lea Botermann; Ulrich Laufs; Charlotte Kloft; Martin Schulz
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

9.  Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.

Authors:  Kevin J Friesen; Cornelius Woelk; Shawn Bugden
Journal:  CMAJ       Date:  2016-04-04       Impact factor: 8.262

10.  Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients.

Authors:  Vagish Hemmige; Charlene A Flash; Josephinel Carter; Thomas P Giordano; Teddy Zerai
Journal:  AIDS Care       Date:  2018-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.